Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ventavis® Registry Protocol (RESPIRE)

This study has been terminated.
(low enrollment and difficulty recruiting eligible patients in adequate time)
Information provided by (Responsible Party):
Actelion Identifier:
First received: May 13, 2009
Last updated: April 9, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)